| Year |
Citation |
Score |
| 2023 |
Liatsou I, Fu Y, Li Z, Hasan M, Guo X, Yu J, Piccolo J, Cartee A, Wang H, Du Y, Bryan J, Gabrielson K, Kraitchman DL, Sgouros G. Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma-a proof of concept study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38108831 DOI: 10.1007/s00259-023-06528-2 |
0.317 |
|
| 2022 |
Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, St James S, Zanzonico PB. Reply LTE, Single time point tumour dosimetry assuming normal distribution of tumour kinetics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35273095 DOI: 10.2967/jnumed.121.263717 |
0.565 |
|
| 2021 |
Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 3S-11S. PMID 34857621 DOI: 10.2967/jnumed.121.262749 |
0.641 |
|
| 2021 |
Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 12S-22S. PMID 34857617 DOI: 10.2967/jnumed.121.262750 |
0.665 |
|
| 2021 |
Howe A, Bhatavdekar O, Salerno D, Josefsson A, Pacheco-Torres J, Bhujwalla ZM, Gabrielson KL, Sgouros G, Sofou S. Combination of carriers, with complementary intratumoral microdistributions of delivered α-particles, may realize the promise for Actinium-225 in large solid tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34795012 DOI: 10.2967/jnumed.121.262992 |
0.699 |
|
| 2021 |
Prasad A, Nair R, Bhatavdekar O, Howe A, Salerno D, Sempkowski M, Josefsson A, Pacheco-Torres J, Bhujwalla ZM, Gabrielson KL, Sgouros G, Sofou S. Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34117896 DOI: 10.1007/s00259-021-05406-z |
0.676 |
|
| 2020 |
Divgi C, Carrasquillo JA, Meredith R, Seo Y, Frey EC, Bolch WE, Zimmerman BE, Akabani G, Jacobson DA, Brown B, Davern SM, Hobbs RF, Humm J, Moros EG, Morse D, ... ... Sgouros G, et al. Overcoming Barriers to Radiopharmaceutical Therapy: An Overview from the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy (RPT). International Journal of Radiation Oncology, Biology, Physics. PMID 33309909 DOI: 10.1016/j.ijrobp.2020.12.002 |
0.645 |
|
| 2020 |
Roncali E, Capala J, Benedict SH, Akabani G, Bednarz B, Bhadrasain V, Bolch WE, Buchsbaum J, Clarke BN, Coleman N, Dewaraja YK, Frey EC, Ghaly M, Grudzinski J, Hobbs RF, ... ... Sgouros G, et al. Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33277396 DOI: 10.2967/jnumed.120.255547 |
0.626 |
|
| 2020 |
Brown JL, Sexton-Stallone B, Li Y, Frey EC, Treves ST, Fahey FH, Plyku D, Cao X, Sgouros G, Bolch WE. Body morphometry appropriate computational phantoms for dose and risk optimization in pediatric renal imaging with Tc-99m DMSA and Tc-99m MAG3. Physics in Medicine and Biology. 65: 235026. PMID 33245053 DOI: 10.1088/1361-6560/Abb1Da |
0.349 |
|
| 2020 |
Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nature Reviews. Drug Discovery. PMID 32895501 DOI: 10.1038/S41573-020-0085-5 |
0.302 |
|
| 2020 |
St James S, Bednarz B, Benedict S, Buchsbaum JC, Dewaraja Y, Frey E, Hobbs R, Grudzinski J, Roncali E, Sgouros G, Capala J, Xiao Y. Current Status of Radiopharmaceutical Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 32805300 DOI: 10.1016/J.Ijrobp.2020.08.035 |
0.451 |
|
| 2020 |
Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nature Reviews. Drug Discovery. PMID 32728208 DOI: 10.1038/S41573-020-0073-9 |
0.373 |
|
| 2020 |
Josefsson A, Siritantikorn K, Ranka S, de Amorim de Carvalho JW, Buchpiguel CA, Sapienza MT, Bolch WE, Sgouros G. Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations. Ejnmmi Research. 10: 26. PMID 32189087 DOI: 10.1186/S13550-020-0614-6 |
0.323 |
|
| 2020 |
Sgouros G. Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters. Seminars in Nuclear Medicine. 50: 124-132. PMID 32172797 DOI: 10.1053/J.Semnuclmed.2019.11.002 |
0.367 |
|
| 2020 |
Liatsou I, Josefsson A, Cortez A, Hobbs RF, Brayton C, Torgue J, Sgouros G. Abstract 5350: RBE, in vivo, for a 212Pb-conjugated anti-HER2/neu antibody Cancer Research. 80: 5350-5350. DOI: 10.1158/1538-7445.Am2020-5350 |
0.414 |
|
| 2019 |
Karimian A, Ji NT, Song H, Sgouros G. Mathematical Modeling of Pre-Clinical Alpha-Emitter Radiopharmaceutical Therapy. Cancer Research. PMID 31772036 DOI: 10.1158/0008-5472.Can-19-2553 |
0.382 |
|
| 2019 |
Morris MJ, Corey E, Guise TA, Gulley JL, Kevin Kelly W, Quinn DI, Scholz A, Sgouros G. Radium-223 mechanism of action: implications for use in treatment combinations. Nature Reviews. Urology. PMID 31712765 DOI: 10.1038/S41585-019-0251-X |
0.316 |
|
| 2019 |
Sgouros G. α-Particle-Emitter Radiopharmaceutical Therapy: Resistance Is Futile. Cancer Research. 79: 5479-5481. PMID 31676677 DOI: 10.1158/0008-5472.Can-19-2806 |
0.329 |
|
| 2019 |
Sgouros G. The Case for Dosimetry in Alpha-Emitter Therapy. Journal of Medical Imaging and Radiation Sciences. PMID 31537496 DOI: 10.1016/J.Jmir.2019.07.007 |
0.389 |
|
| 2019 |
Ray Banerjee S, Minn IL, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess A, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG. Preclinical evaluation of Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31253744 DOI: 10.2967/Jnumed.119.229393 |
0.348 |
|
| 2019 |
Sgouros G. Radiopharmaceutical Therapy. Health Physics. 116: 175-178. PMID 30585960 DOI: 10.1097/HP.0000000000001000 |
0.314 |
|
| 2019 |
Sgouros G, He B, Frey E, Berger M, Ludwig D. Impact of Target Cell Number on Target Cell and Tissue Dose for Antibody-Mediated Delivery of Alpha-Emitters Journal of Medical Imaging and Radiation Sciences. 50: S38. DOI: 10.1016/J.Jmir.2019.03.116 |
0.367 |
|
| 2019 |
Tworowska I, Delpassand ES, Bolek L, Shanoon F, Sgouros G, Frey E, He B, Muzammil A, Ghaly M, Stallons T, Saidi A, Torgue J. Targeted Alpha-emitter Therapy of Neuroendocrine Tumors using 212Pb-octreotate (AlphaMedix TM) Journal of Medical Imaging and Radiation Sciences. 50: S34. DOI: 10.1016/J.Jmir.2019.03.104 |
0.376 |
|
| 2019 |
Cortez A, Nedrow J, Josefsson A, Shtekler A, Rao A, Austin Z, Hobbs R, Sgouros G. Evaluation of 225Ac-anti-VLA-4 for Targeted α-therapy for Treatment of Metastatic Melanoma Journal of Medical Imaging and Radiation Sciences. 50. DOI: 10.1016/J.Jmir.2019.03.048 |
0.326 |
|
| 2018 |
Khamwan K, O'Reilly SE, Plyku D, Goodkind A, Josefsson A, Cao X, Fahey FH, Treves ST, Bolch WE, Sgouros G. Re-evaluation of pediatric 18F-FDG dosimetry: Cristy-Eckerman versus UF/NCI hybrid computational phantoms. Physics in Medicine and Biology. PMID 30022768 DOI: 10.1088/1361-6560/Aad47A |
0.331 |
|
| 2018 |
Sgouros G, Hobbs R, Josefsson A. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides. Current Radiopharmaceuticals. 11: 209-214. PMID 29697036 DOI: 10.2174/1874471011666180426130058 |
0.351 |
|
| 2018 |
Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF. Combined model-based and patient-specific dosimetry forF-DCFPyL, a PSMA-targeted PET agent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29460025 DOI: 10.1007/S00259-018-3939-X |
0.32 |
|
| 2018 |
Josefsson A, Hobbs RF, Ranka S, Schwarz BC, Plyku D, de Carvalho JWA, Buchpiguel CA, Tatit Sapienza M, Bolch WE, Sgouros G. Comparative Dosimetry forGa-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29439017 DOI: 10.2967/Jnumed.117.203893 |
0.342 |
|
| 2018 |
McDevitt MR, Sgouros G, Sofou S. Targeted and Nontargeted α-Particle Therapies. Annual Review of Biomedical Engineering. PMID 29345977 DOI: 10.1146/Annurev-Bioeng-062117-120931 |
0.684 |
|
| 2017 |
Park S, Nedrow JR, Josefsson A, Sgouros G. Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV.f.HuHER2 mice: characterization and use in a model of metastatic breast cancer. Oncotarget. 8: 68071-68082. PMID 28978097 DOI: 10.18632/Oncotarget.19174 |
0.348 |
|
| 2017 |
Nedrow JR, Josefsson A, Park S, Bäck T, Hobbs RF, Brayton C, Bruchertseifer F, Morgenstern A, Sgouros G. Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model. Ejnmmi Research. 7: 57. PMID 28721684 DOI: 10.1186/S13550-017-0303-2 |
0.366 |
|
| 2017 |
Fahey FH, Goodkind AB, Plyku D, Khamwan K, O'Reilly SE, Cao X, Frey EC, Li Y, Bolch WE, Sgouros G, Treves ST. Dose Estimation in Pediatric Nuclear Medicine. Seminars in Nuclear Medicine. 47: 118-125. PMID 28237000 DOI: 10.1053/J.Semnuclmed.2016.10.006 |
0.325 |
|
| 2017 |
Plyku D, Hobbs RF, Huang K, Atkins F, Garcia C, Sgouros G, Van Nostrand D. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28104741 DOI: 10.2967/Jnumed.116.179366 |
0.308 |
|
| 2016 |
Yue J, Hobbs R, Sgouros G, Frey E. SU-F-J-08: Quantitative SPECT Imaging of Ra-223 in a Phantom. Medical Physics. 43: 3407. PMID 28048785 DOI: 10.1118/1.4955916 |
0.374 |
|
| 2016 |
Chen Y, Lisok A, Chatterjee S, Wharram B, Pullambhatla M, Wang Y, Sgouros G, Mease RC, Pomper MG. A [18F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance. Bioconjugate Chemistry. PMID 27270097 DOI: 10.1021/Acs.Bioconjchem.6B00195 |
0.314 |
|
| 2016 |
Kiess A, Minn IL, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel M, Mease RC, Sgouros G, Zalutsky MR, et al. (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230930 DOI: 10.2967/Jnumed.116.174300 |
0.353 |
|
| 2016 |
Yoshida T, Jin K, Song H, Park S, Huso DL, Zhang Z, Liangfeng H, Zhu C, Bruchertseifer F, Morgenstern A, Sgouros G, Sukumar S. Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer. Oncotarget. PMID 27119227 DOI: 10.18632/Oncotarget.8949 |
0.396 |
|
| 2016 |
O'Reilly SE, Plyku D, Sgouros G, Fahey FH, Ted Treves S, Frey EC, Bolch WE. A risk index for pediatric patients undergoing diagnostic imaging with (99m)Tc-dimercaptosuccinic acid that accounts for body habitus. Physics in Medicine and Biology. 61: 2319-32. PMID 26930549 DOI: 10.1088/0031-9155/61/6/2319 |
0.339 |
|
| 2016 |
Nedrow J, Josefsson A, Park S, Ranka S, Sgouros G. Abstract LB-183: The impact of protein concentration on the distribution of 111In-antibody conjugate for imaging of programmed death-ligand 1 (PD-L1) Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-183 |
0.303 |
|
| 2016 |
Park S, Sgouros G. Abstract 4279: Human HER2-overexpressing mouse breast cancer cell lines derived from MMTV.f.HuHER2 mice: characterization and use in a model of metastatic breast cancer Cancer Research. 76: 4279-4279. DOI: 10.1158/1538-7445.Am2016-4279 |
0.309 |
|
| 2016 |
Josefsson A, Nedrow JR, Park S, Ranka S, Sgouros G. Abstract 3052: Combining α-particle radiopharmaceutical therapy using Actinium-225 and immunotherapy with anti-PD-L1 antibodies in a murine immunocompetent metastatic breast cancer model Cancer Research. 76: 3052-3052. DOI: 10.1158/1538-7445.Am2016-3052 |
0.306 |
|
| 2016 |
Hobbs RF, Josefsson A, Mauxion T, Frey E, Plyku D, Meyer C, Terezakis S, Sgouros G, Loeb D. Preliminary Results from a Combined 153Sm-EDTMP and External Beam Radiation Therapy for Metastatic Osteosarcoma Patients Using Prospective Absorbed Dose-Based Treatment Planning Brachytherapy. 15: S136. DOI: 10.1016/J.Brachy.2016.04.232 |
0.337 |
|
| 2015 |
Plyku D, Loeb DM, Prideaux AR, Baechler S, Wahl RL, Sgouros G, Hobbs RF. Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry. Cancer Biotherapy & Radiopharmaceuticals. 30: 369-79. PMID 26560193 DOI: 10.1089/Cbr.2014.1803 |
0.38 |
|
| 2015 |
Josefsson A, Nedrow JR, Park S, Ray Banerjee S, Rittenbach A, Jammes F, Tsui B, Sgouros G. Imaging, biodistribution, and dosimetry of radionuclide-labeled PD-L1 antibody in an immunocompetent mouse model of breast cancer. Cancer Research. PMID 26554829 DOI: 10.1158/0008-5472.Can-15-2141 |
0.304 |
|
| 2015 |
Woliner-van der Weg W, Schoffelen R, Hobbs RF, Gotthardt M, Goldenberg DM, Sharkey RM, Slump CH, van der Graaf WT, Oyen WJ, Boerman OC, Sgouros G, Visser EP. Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy. Ejnmmi Physics. 2: 5. PMID 26501807 DOI: 10.1186/S40658-014-0104-X |
0.363 |
|
| 2015 |
Hobbs R, Mauxion T, Duran R, Yue J, Lin M, Lodge M, Sgouros G, Wahl R, Geschwind J, Herman J, Frey E. Prospective Absorbed Dose-Based Treatment Planning in Y-90 Microsphere Therapy for Liver Cancer Using Tc-99m: A Feasibility Study International Journal of Radiation Oncology*Biology*Physics. 93: E144. DOI: 10.1016/J.Ijrobp.2015.07.914 |
0.319 |
|
| 2015 |
Josefsson A, Zhu C, Park S, Abou D, Song H, Huso D, Back T, Bruchertseifer F, Morgenstern A, Bolch W, Sgouros G, Hobbs R. Small Scale Renal Dosimetry for Alpha Particle Radiopharmaceutical Therapy of Metastatic Breast Cancer With 225Ac-7.16.4 International Journal of Radiation Oncology*Biology*Physics. 93: S149-S150. DOI: 10.1016/J.Ijrobp.2015.07.355 |
0.318 |
|
| 2015 |
Josefsson A, Kiess A, Minn I, Mease R, Brummet M, Baidoo K, Brechbiel M, Sgouros G, Pomper M, Hobbs R. Macro to Microdosimetric Analysis for Alpha Particle Radiopharmaceutical Therapy for [211At]YC-I-27, a PSMA-Targeting Ligand for Metastatic Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S148-S149. DOI: 10.1016/J.Ijrobp.2015.07.352 |
0.336 |
|
| 2014 |
Cheng L, Hobbs RF, Sgouros G, Frey EC. Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy. Medical Physics. 41: 112507. PMID 25370666 DOI: 10.1118/1.4897613 |
0.361 |
|
| 2014 |
Sgouros G, Goldenberg DM. Radiopharmaceutical therapy in the era of precision medicine. European Journal of Cancer (Oxford, England : 1990). 50: 2360-3. PMID 24953565 DOI: 10.1016/J.Ejca.2014.04.025 |
0.375 |
|
| 2014 |
Sgouros G, Hobbs RF, Abou DS. The role of preclinical models in radiopharmaceutical therapy. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. e121-5. PMID 24857091 DOI: 10.14694/EdBook_AM.2014.34.e121 |
0.326 |
|
| 2014 |
Sgouros G, Hobbs RF. Dosimetry for radiopharmaceutical therapy. Seminars in Nuclear Medicine. 44: 172-8. PMID 24832581 DOI: 10.1053/J.Semnuclmed.2014.03.007 |
0.454 |
|
| 2014 |
Hobbs RF, Howell RW, Song H, Baechler S, Sgouros G. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy. Radiation Research. 181: 90-8. PMID 24502376 DOI: 10.1667/Rr13483.1 |
0.375 |
|
| 2013 |
Hobbs RF, Le Y, Armour E, Efron J, Azad N, Diaz L, Wahl R, Sgouros G, Gearhardt S, Hermann J. Voxelized Dose--FDG-PET Response in HDR Brachytherapy of Rectal Cancer. Practical Radiation Oncology. 3: S28-9. PMID 24674533 DOI: 10.1016/J.Prro.2013.01.097 |
0.338 |
|
| 2013 |
Botta F, Mairani A, Hobbs RF, Vergara Gil A, Pacilio M, Parodi K, Cremonesi M, Coca Pérez MA, Di Dia A, Ferrari M, Guerriero F, Battistoni G, Pedroli G, Paganelli G, Torres Aroche LA, ... Sgouros G, et al. Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images. Physics in Medicine and Biology. 58: 8099-120. PMID 24200697 DOI: 10.1088/0031-9155/58/22/8099 |
0.308 |
|
| 2013 |
Dewaraja YK, Ljungberg M, Green AJ, Zanzonico PB, Frey EC, Bolch WE, Brill AB, Dunphy M, Fisher DR, Howell RW, Meredith RF, Sgouros G, Wessels BW. MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2182-8. PMID 24130233 DOI: 10.2967/Jnumed.113.122390 |
0.674 |
|
| 2013 |
Hobbs RF, Wahl RL, Frey EC, Kasamon Y, Song H, Huang P, Jones RJ, Sgouros G. Radiobiologic optimization of combination radiopharmaceutical therapy applied to myeloablative treatment of non-Hodgkin lymphoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1535-42. PMID 23918734 DOI: 10.2967/Jnumed.112.117952 |
0.35 |
|
| 2013 |
Song H, Hedayati M, Hobbs RF, Shao C, Bruchertseifer F, Morgenstern A, Deweese TL, Sgouros G. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody. Molecular Cancer Therapeutics. 12: 2043-54. PMID 23873849 DOI: 10.1158/1535-7163.Mct-13-0108 |
0.375 |
|
| 2013 |
Cheng L, Hobbs RF, Segars PW, Sgouros G, Frey EC. Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters. Physics in Medicine and Biology. 58: 3631-47. PMID 23648371 DOI: 10.1088/0031-9155/58/11/3631 |
0.345 |
|
| 2013 |
Song H, Guerrero-Cazares H, Horti A, Wahl RL, Quinones-Hinojosa A, Sgouros G. Abstract 4533: Synthesis and biodistribution of225Ac-substance P for intracavitary radiopharmaceutical therapy of high-grade recurrent glioma. Cancer Research. 73: 4533-4533. DOI: 10.1158/1538-7445.Am2013-4533 |
0.387 |
|
| 2013 |
Hobbs R, Sgouros G, Howell R. SU‐E‐J‐184: A Dose‐Independent Relative Biological Effect Quantity for Targeted Alpha‐Particle Therapy in the EQD2 Formalism Medical Physics. 40: 193-193. DOI: 10.1118/1.4814396 |
0.374 |
|
| 2012 |
Cho SY, Gage KL, Mease RC, Senthamizhchelvan S, Holt DP, Jeffrey-Kwanisai A, Endres CJ, Dannals RF, Sgouros G, Lodge M, Eisenberger MA, Rodriguez R, Carducci MA, Rojas C, Slusher BS, et al. Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1883-91. PMID 23203246 DOI: 10.2967/Jnumed.112.104661 |
0.341 |
|
| 2012 |
Sgouros G, Zanzonico P. Humm recognized with Loevinger-Berman Award. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 20N. PMID 23124873 |
0.558 |
|
| 2012 |
Baechler S, Hobbs RF, Boubaker A, Buchegger F, He B, Frey EC, Sgouros G. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy. Medical Physics. 39: 6118-28. PMID 23039651 DOI: 10.1118/1.4752213 |
0.309 |
|
| 2012 |
Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, Ljungberg M. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1310-25. PMID 22743252 DOI: 10.2967/Jnumed.111.100123 |
0.671 |
|
| 2012 |
Hobbs RF, Song H, Huso DL, Sundel MH, Sgouros G. A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry. Physics in Medicine and Biology. 57: 4403-24. PMID 22705986 DOI: 10.1088/0031-9155/57/13/4403 |
0.352 |
|
| 2012 |
Hobbs RF, Song H, Watchman CJ, Bolch WE, Aksnes AK, Ramdahl T, Flux GD, Sgouros G. A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy. Physics in Medicine and Biology. 57: 3207-22. PMID 22546715 DOI: 10.1088/0031-9155/57/10/3207 |
0.349 |
|
| 2012 |
Cheng Y, Senthamizhchelvan S, Agarwal R, Green GM, Mease RC, Sgouros G, Huso DL, Pomper MG, Meltzer SJ, Abraham JM. [32P]ATP inhibits the growth of xenografted tumors in nude mice. Cell Cycle (Georgetown, Tex.). 11: 1878-82. PMID 22544324 DOI: 10.4161/Cc.19955 |
0.346 |
|
| 2012 |
Liu G, Moake M, Har-el YE, Long CM, Chan KW, Cardona A, Jamil M, Walczak P, Gilad AA, Sgouros G, van Zijl PC, Bulte JW, McMahon MT. In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 67: 1106-13. PMID 22392814 DOI: 10.1002/Mrm.23100 |
0.312 |
|
| 2012 |
Weiss VL, Lee TH, Song H, Kouo TS, Black CM, Sgouros G, Jaffee EM, Armstrong TD. Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells. Plos One. 7: e31962. PMID 22359647 DOI: 10.1371/Journal.Pone.0031962 |
0.321 |
|
| 2012 |
Wayson M, Lee C, Sgouros G, Treves ST, Frey E, Bolch WE. Internal photon and electron dosimetry of the newborn patient--a hybrid computational phantom study. Physics in Medicine and Biology. 57: 1433-57. PMID 22354044 DOI: 10.1088/0031-9155/57/5/1433 |
0.344 |
|
| 2012 |
Senthamizhchelvan S, Hobbs RF, Song H, Frey EC, Zhang Z, Armour E, Wahl RL, Loeb DM, Sgouros G. Tumor dosimetry and response for 153Sm-ethylenediamine tetramethylene phosphonic acid therapy of high-risk osteosarcoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 215-24. PMID 22251554 DOI: 10.2967/Jnumed.111.096677 |
0.352 |
|
| 2012 |
Song H, Senthamizhchelvan S, Hobbs RF, Sgouros G. Alpha Particle Emitter Radiolabeled Antibody for Metastatic Cancer: What Can We Learn from Heavy Ion Beam Radiobiology? Antibodies. 1: 124-148. DOI: 10.3390/Antib1020124 |
0.389 |
|
| 2011 |
Sgouros G, Hobbs RF, Song H. Modelling and dosimetry for alpha-particle therapy. Current Radiopharmaceuticals. 4: 261-5. PMID 22201712 DOI: 10.2174/1874471011104030261 |
0.36 |
|
| 2011 |
Sgouros G, Frey EC, Bolch WE, Wayson MB, Abadia AF, Treves ST. An approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc-dimercaptosuccinic acid. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1923-9. PMID 22144506 DOI: 10.2967/Jnumed.111.092221 |
0.314 |
|
| 2011 |
Hobbs RF, Baechler S, Fu DX, Esaias C, Pomper MG, Ambinder RF, Sgouros G. A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy. Medical Physics. 38: 2892-903. PMID 21815364 DOI: 10.1118/1.3576051 |
0.385 |
|
| 2011 |
Sgouros G, Hobbs RF, Atkins FB, Van Nostrand D, Ladenson PW, Wahl RL. Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 38: S41-7. PMID 21484384 DOI: 10.1007/S00259-011-1769-1 |
0.333 |
|
| 2011 |
Song H, Sgouros G. Radioimmunotherapy of solid tumors: searching for the right target. Current Drug Delivery. 8: 26-44. PMID 21034423 DOI: 10.2174/156720111793663651 |
0.37 |
|
| 2011 |
Hobbs RF, McNutt T, Baechler S, He B, Esaias CE, Frey EC, Loeb DM, Wahl RL, Shokek O, Sgouros G. A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 80: 1256-62. PMID 20950958 DOI: 10.1016/J.Ijrobp.2010.08.022 |
0.355 |
|
| 2011 |
Song H, Hobbs RF, Shao C, Sgouros G. Abstract 5081: Inhibiting DNA double strand break repair for alpha radioimmunotherapy Cancer Research. 71: 5081-5081. DOI: 10.1158/1538-7445.Am2011-5081 |
0.368 |
|
| 2011 |
Hobbs R, Song H, Huso D, Sgouros G. SU‐E‐T‐324: A Nephron‐Based Dosimetry Model for Alpha‐Particle Radiopharmaceutical Therapy Medical Physics. 38: 3562-3562. DOI: 10.1118/1.3612278 |
0.351 |
|
| 2010 |
Baechler S, Hobbs RF, Jacene HA, Bochud FO, Wahl RL, Sgouros G. Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1878-84. PMID 21098795 DOI: 10.2967/Jnumed.110.079947 |
0.312 |
|
| 2010 |
Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, Heaney ML, Chanel S, Morgenstern A, Sgouros G, Larson SM, Scheinberg DA, Jurcic JG. Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5303-11. PMID 20858843 DOI: 10.1158/1078-0432.Ccr-10-0382 |
0.35 |
|
| 2010 |
Dieudonné A, Hobbs RF, Bolch WE, Sgouros G, Gardin I. Fine-resolution voxel S values for constructing absorbed dose distributions at variable voxel size. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1600-7. PMID 20847175 DOI: 10.2967/Jnumed.110.077149 |
0.314 |
|
| 2010 |
Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM. Human biodistribution and radiation dosimetry of 82Rb. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1592-9. PMID 20847168 DOI: 10.2967/Jnumed.110.077669 |
0.345 |
|
| 2010 |
Lingappa M, Song H, Thompson S, Bruchertseifer F, Morgenstern A, Sgouros G. Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer. Cancer Research. 70: 6815-23. PMID 20651254 DOI: 10.1158/0008-5472.Can-09-4548 |
0.344 |
|
| 2010 |
Hobbs RF, Baechler S, Wahl RL, He B, Song H, Esaias CE, Frey EC, Jacene H, Sgouros G. Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 368-75. PMID 20150265 DOI: 10.2967/Jnumed.109.069575 |
0.322 |
|
| 2010 |
Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, Brill AB, Song H, Howell RW, Akabani G, Bolch WE, Brill AB, Fisher DR, Howell RW, ... ... Sgouros G, et al. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 311-28. PMID 20080889 DOI: 10.2967/Jnumed.108.058651 |
0.655 |
|
| 2010 |
Sofou S, Enmon R, Palm S, Kappel B, Zanzonico P, McDevitt MR, Scheinberg DA, Sgouros G. Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research. 20: 330-40. PMID 20070139 DOI: 10.3109/08982100903544185 |
0.764 |
|
| 2010 |
Jentzen W, Hobbs RF, Stahl A, Knust J, Sgouros G, Bockisch A. Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 37: 884-95. PMID 20069293 DOI: 10.1007/S00259-009-1351-2 |
0.348 |
|
| 2010 |
Lewington V, Parker C, Hindorf C, Flux G, Chittenden S, Sgouros G, O'Bryan-Tear G, Aksnes A. Radium-223 chloride, a first-in-class alpha-pharmaceutical for patients with castration-resistant prostate cancer (CRPC) and bone metastases: Biodistribution/dosimetry compared to overall safety profile. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E15009 |
0.302 |
|
| 2009 |
Song H, Hobbs RF, Vajravelu R, Huso DL, Esaias C, Apostolidis C, Morgenstern A, Sgouros G. Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y. Cancer Research. 69: 8941-8. PMID 19920193 DOI: 10.1158/0008-5472.Can-09-1828 |
0.327 |
|
| 2009 |
Hobbs RF, Wahl RL, Lodge MA, Javadi MS, Cho SY, Chien DT, Ewertz ME, Esaias CE, Ladenson PW, Sgouros G. 124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1844-7. PMID 19837771 DOI: 10.2967/Jnumed.109.066738 |
0.352 |
|
| 2009 |
He B, Wahl RL, Sgouros G, Du Y, Jacene H, Kasecamp WR, Flinn I, Hammes RJ, Bianco J, Kahl B, Frey EC. Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studies. Medical Physics. 36: 1595-601. PMID 19544775 DOI: 10.1118/1.3100265 |
0.319 |
|
| 2009 |
Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD, Scott T, Schwartz CL. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer. 115: 2514-22. PMID 19338063 DOI: 10.1002/Cncr.24286 |
0.3 |
|
| 2009 |
He B, Du Y, Segars WP, Wahl RL, Sgouros G, Jacene H, Frey EC. Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake. Medical Physics. 36: 612-9. PMID 19292001 DOI: 10.1118/1.3063156 |
0.313 |
|
| 2009 |
Sgouros G, Howell RW, Bolch WE, Fisher DR. MIRD commentary: proposed name for a dosimetry unit applicable to deterministic biological effects--the barendsen (Bd). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 485-7. PMID 19258259 DOI: 10.2967/Jnumed.108.057398 |
0.337 |
|
| 2009 |
Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 477-84. PMID 19258258 DOI: 10.2967/Jnumed.108.056036 |
0.355 |
|
| 2009 |
Hobbs R, Fu D, Pomper M, Ambinder R, Sgouros G. Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling Infectious Agents and Cancer. 4. DOI: 10.1186/1750-9378-4-S2-P23 |
0.381 |
|
| 2009 |
Sgouros G. TU‐D‐303A‐04: Immunoliposomes for Targeted Radionuclide Therapy Medical Physics. 36: 2736-2736. DOI: 10.1118/1.3182388 |
0.386 |
|
| 2008 |
Hobbs R, Song H, Sgouros G. Poster - Thurs Eve-11: Quantitative imaging of 213Bi alpha-emitter with a beta-imager. Medical Physics. 35: 3403. PMID 28512796 DOI: 10.1118/1.2965930 |
0.367 |
|
| 2008 |
Baechler S, Hobbs RF, Prideaux AR, Recordon M, Bischof-Delaloye A, Sgouros G. Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan. Cancer Biotherapy & Radiopharmaceuticals. 23: 633-9. PMID 18999935 DOI: 10.1089/Cbr.2008.0506 |
0.302 |
|
| 2008 |
Sgouros G. Update: molecular radiotherapy: survey and current status. Cancer Biotherapy & Radiopharmaceuticals. 23: 531-40. PMID 18999928 DOI: 10.1089/Cbr.2008.0502 |
0.379 |
|
| 2008 |
Wessels BW, Konijnenberg MW, Dale RG, Breitz HB, Cremonesi M, Meredith RF, Green AJ, Bouchet LG, Brill AB, Bolch WE, Sgouros G, Thomas SR. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1884-99. PMID 18927342 DOI: 10.2967/Jnumed.108.053173 |
0.362 |
|
| 2008 |
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nature Medicine. 14: 1118-22. PMID 18776891 DOI: 10.1038/Nm.1864 |
0.371 |
|
| 2008 |
Sgouros G, Frey E, Wahl R, He B, Prideaux A, Hobbs R. Three-dimensional imaging-based radiobiological dosimetry. Seminars in Nuclear Medicine. 38: 321-34. PMID 18662554 DOI: 10.1053/J.Semnuclmed.2008.05.008 |
0.364 |
|
| 2008 |
Sgouros G. Alpha-particles for targeted therapy. Advanced Drug Delivery Reviews. 60: 1402-6. PMID 18541332 DOI: 10.1016/J.Addr.2008.04.007 |
0.366 |
|
| 2008 |
Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, Prideaux A, Fox JJ, Sgouros G, Kozikowski AP, Pomper MG. N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L- cysteine, [18F]DCFBC: A new Imaging probe for prostate cancer Clinical Cancer Research. 14: 3036-3043. PMID 18483369 DOI: 10.1158/1078-0432.Ccr-07-1517 |
0.347 |
|
| 2008 |
Song H, Shahverdi K, Huso DL, Esaias C, Fox J, Liedy A, Liedy A, Zhang Z, Reilly RT, Apostolidis C, Morgenstern A, Sgouros G. 213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model. Cancer Research. 68: 3873-80. PMID 18483272 DOI: 10.1158/0008-5472.Can-07-6308 |
0.37 |
|
| 2008 |
Baechler S, Hobbs RF, Prideaux AR, Wahl RL, Sgouros G. Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry. Medical Physics. 35: 1123-34. PMID 18404947 DOI: 10.1118/1.2836421 |
0.354 |
|
| 2008 |
Kim PS, Armstrong TD, Song H, Wolpoe ME, Weiss V, Manning EA, Huang LQ, Murata S, Sgouros G, Emens LA, Reilly RT, Jaffee EM. Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs. The Journal of Clinical Investigation. 118: 1700-11. PMID 18398507 DOI: 10.1172/Jci34333 |
0.314 |
|
| 2008 |
Sgouros G, Song H. Cancer stem cell targeting using the alpha-particle emitter, 213Bi: mathematical modeling and feasibility analysis. Cancer Biotherapy & Radiopharmaceuticals. 23: 74-81. PMID 18298331 DOI: 10.1089/Cbr.2007.0408 |
0.369 |
|
| 2008 |
Sofou S, Sgouros G. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opinion On Drug Delivery. 5: 189-204. PMID 18248318 DOI: 10.1517/17425247.5.2.189 |
0.685 |
|
| 2008 |
Sgouros G. MO‐E‐342‐03: Radionuclide Therapy and Dosimetry in Nuclear Medicine Medical Physics. 35: 2880-2880. DOI: 10.1118/1.2962409 |
0.404 |
|
| 2007 |
Sofou S, Kappel BJ, Jaggi JS, McDevitt MR, Scheinberg DA, Sgouros G. Enhanced retention of the α-particle-emitting daughters of actinium-225 by liposome carriers Bioconjugate Chemistry. 18: 2061-2067. PMID 17935286 DOI: 10.1021/Bc070075T |
0.7 |
|
| 2007 |
Sgouros G, Knox SJ, Joiner MC, Morgan WF, Kassis AI. MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1683-91. PMID 17873139 DOI: 10.2967/Jnumed.105.028183 |
0.339 |
|
| 2007 |
Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, Schwartz J, Beattie B, Kappel BJ, Chattopadhyay D, Xiao J, Sgouros G, Larson SM, Scheinberg DA. Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. The Journal of Clinical Investigation. 117: 2422-30. PMID 17717602 DOI: 10.1172/Jci32226 |
0.704 |
|
| 2007 |
Petoussi-Henss N, Bolch WE, Zankl M, Sgouros G, Wessels B. Patient-specific scaling of reference S-values for cross-organ radionuclide S-values: What is appropriate? Radiation Protection Dosimetry. 127: 192-196. PMID 17569687 DOI: 10.1093/Rpd/Ncm270 |
0.311 |
|
| 2007 |
Prideaux AR, Song H, Hobbs RF, He B, Frey EC, Ladenson PW, Wahl RL, Sgouros G. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1008-16. PMID 17504874 DOI: 10.2967/Jnumed.106.038000 |
0.373 |
|
| 2007 |
Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, Schwartz J, Beattie B, Kappel BJ, Chattopadhyay D, Xiao J, Sgouros G, Larson SM, Scheinberg DA. Erratum: Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor (Journal of Clinical Investigation (2007) 117, (2422-2430) DOI: 10.1172/JCI32226)) Journal of Clinical Investigation. 117. DOI: 10.1172/Jci32226C1 |
0.659 |
|
| 2006 |
Jaggi JS, Seshan SV, McDevitt MR, Sgouros G, Hyjek E, Scheinberg DA. Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys. International Journal of Radiation Oncology, Biology, Physics. 64: 1503-12. PMID 16503385 DOI: 10.1016/J.Ijrobp.2005.11.036 |
0.315 |
|
| 2005 |
Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud AM, Sgouros G. Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids. Journal of Liposome Research. 15: 15-27. PMID 16194925 DOI: 10.1081/Lpr-64953 |
0.555 |
|
| 2005 |
Jaggi JS, Kappel BJ, McDevitt MR, Sgouros G, Flombaum CD, Cabassa C, Scheinberg DA. Efforts to control the errant products of a targeted in vivo generator. Cancer Research. 65: 4888-95. PMID 15930310 DOI: 10.1158/0008-5472.Can-04-3096 |
0.329 |
|
| 2005 |
Emfietzoglou D, Kostarelos K, Papakostas A, Yang WH, Ballangrud A, Song H, Sgouros G. Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 89-97. PMID 15632038 |
0.53 |
|
| 2004 |
Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud A, Sgouros G. Binding and interstitial penetration of liposomes within avascular tumor spheroids. International Journal of Cancer. 112: 713-21. PMID 15382056 DOI: 10.1002/Ijc.20457 |
0.562 |
|
| 2004 |
Sgouros G. Introduction to kidney dose-response for radionuclide therapy. Cancer Biotherapy and Radiopharmaceuticals. 19: 357-358. PMID 15285882 DOI: 10.1089/1084978041425061 |
0.379 |
|
| 2004 |
Ballangrud AM, Yang WH, Palm S, Enmon R, Borchardt PE, Pellegrini VA, McDevitt MR, Scheinberg DA, Sgouros G. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4489-97. PMID 15240541 DOI: 10.1158/1078-0432.Ccr-03-0800 |
0.333 |
|
| 2004 |
Sofou S, Thomas JL, Lin HY, McDevitt MR, Scheinberg DA, Sgouros G. Engineered liposomes for potential alpha-particle therapy of metastatic cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 253-60. PMID 14960644 |
0.724 |
|
| 2004 |
Flinn IW, Kahl BS, Frey E, Bianco JA, Hammes RJ, Billing LS, Swinnen LJ, Sgouros G, Wahl RL. Dose Finding Trial of Yttrium 90 (90Y) Ibritumomab Tiuxetan with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL). Blood. 104: 897-897. DOI: 10.1182/Blood.V104.11.897.897 |
0.304 |
|
| 2003 |
Burke JM, Caron PC, Papadopoulos EB, Divgi CR, Sgouros G, Panageas KS, Finn RD, Larson SM, O'Reilly RJ, Scheinberg DA, Jurcic JG. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias Bone Marrow Transplantation. 32: 549-556. PMID 12953125 DOI: 10.1038/Sj.Bmt.1704201 |
0.303 |
|
| 2003 |
Palm S, Enmon RM, Matei C, Kolbert KS, Xu S, Zanzonico PB, Finn RL, Koutcher JA, Larson SM, Sgouros G. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 1148-55. PMID 12843231 |
0.61 |
|
| 2002 |
Behr TM, Béhé M, Sgouros G. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings. Cancer Biotherapy & Radiopharmaceuticals. 17: 445-64. PMID 12396708 DOI: 10.1089/108497802760363231 |
0.376 |
|
| 2002 |
O'Donoghue JA, Baidoo N, Deland D, Welt S, Divgi CR, Sgouros G. Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy. Cancer Biotherapy & Radiopharmaceuticals. 17: 435-43. PMID 12396707 DOI: 10.1089/108497802760363222 |
0.354 |
|
| 2002 |
DeNardo GL, Schlom J, Buchsbaum DJ, Meredith RF, O'Donoghue JA, Sgouros G, Humm JL, DeNardo SJ. Rationales, evidence, and design considerations for fractionated radioimmunotherapy. Cancer. 94: 1332-48. PMID 11877764 DOI: 10.1002/Cncr.10304 |
0.406 |
|
| 2002 |
Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, Ballangrud ÅM, Hamacher KA, Ma D, Humm JL, Brechbiel MW, Molinet R, Scheinberg DA. Targeted α particle immunotherapy for myeloid leukemia Blood. 100: 1233-1239. DOI: 10.1182/Blood.V100.4.1233.H81602001233_1233_1239 |
0.345 |
|
| 2002 |
Zaidi H, Sgouros G. Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine Medical Physics. 30: 2566-2567. DOI: 10.1118/1.1603742 |
0.361 |
|
| 2001 |
Hamacher KA, Sgouros G. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters. Medical Physics. 28: 1857-1874. PMID 11585217 DOI: 10.1118/1.1395026 |
0.384 |
|
| 2000 |
Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. European Journal of Nuclear Medicine. 27: 753-65. PMID 10952487 DOI: 10.1007/S002590000272 |
0.31 |
|
| 1999 |
Hamacher KA, Sgouros G. A schema for estimating absorbed dose to organs following the administration of radionuclides with multiple unstable daughters: a matrix approach. Medical Physics. 26: 2526-2528. PMID 10619234 DOI: 10.1118/1.598788 |
0.32 |
|
| 1999 |
Griffiths GL, Govindan SV, Sgouros G, Ong GL, Goldenberg DM, Mattes MJ. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies. International Journal of Cancer. Journal International Du Cancer. 81: 985-92. PMID 10362149 DOI: 10.1002/(Sici)1097-0215(19990611)81:6<985::Aid-Ijc23>3.0.Co;2-W |
0.336 |
|
| 1999 |
McDevitt MR, Finn RD, Sgouros G, Ma D, Scheinberg DA. An 225Ac/213Bi generator system for therapeutic clinical applications: Construction and operation Applied Radiation and Isotopes. 50: 895-904. PMID 10214708 DOI: 10.1016/S0969-8043(98)00151-1 |
0.319 |
|
| 1998 |
Sgouros G. Yttrium‐90 biodistribution by yttrium‐87 imaging: A theoretical feasibility analysis Medical Physics. 25: 1487-1490. PMID 9725138 DOI: 10.1118/1.598323 |
0.318 |
|
| 1998 |
McDevitt MR, Sgouros G, Finn RD, Humm JL, Jurcic JG, Larson SM, Scheinberg DA. Radioimmunotherapy with alpha-emitting nuclides European Journal of Nuclear Medicine. 25: 1341-1351. PMID 9724387 DOI: 10.1007/S002590050306 |
0.324 |
|
| 1998 |
Sgouros G, O'Donoghue JA, Larson SM, Macapinlac H, Larson JJ, Kemeny N. Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases. International Journal of Radiation Oncology, Biology, Physics. 41: 1177-83. PMID 9719130 DOI: 10.1016/S0360-3016(98)00175-8 |
0.366 |
|
| 1998 |
Behr TM, Sgouros G, Vougioukas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. Therapeutic efficacy and dose-limiting toxicity of auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: Evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model International Journal of Cancer. 76: 738-748. PMID 9610734 DOI: 10.1002/(Sici)1097-0215(19980529)76:5<738::Aid-Ijc20>3.0.Co;2-Z |
0.356 |
|
| 1997 |
Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: Improved cancer therapy administered to a nude mouse Model in relation to the internal radiation dosimetry Cancer. 80: 2591-2610. PMID 9406714 DOI: 10.1002/(Sici)1097-0142(19971215)80:12+<2591::Aid-Cncr35>3.0.Co;2-5 |
0.394 |
|
| 1997 |
Larson SM, El-Shirbiny AM, Divgi CR, Sgouros G, Finn RD, Tschmelitsch J, Picon A, Whitlow M, Schlom J, Zhang J, Cohen AM. Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liver. Cancer. 80: 2458-2468. PMID 9406696 DOI: 10.1002/(Sici)1097-0142(19971215)80:12+<2458::Aid-Cncr17>3.0.Co;2-B |
0.386 |
|
| 1997 |
Furhang EE, Chui CS, Kolbert KS, Larson SM, Sgouros G. Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy. Medical Physics. 24: 1163-1172. PMID 9243479 DOI: 10.1118/1.598018 |
0.361 |
|
| 1997 |
Larson SM, Divgi CR, Scott A, Sgouros G, Graham MC, Kostakoglu L, Scheinberg D, Cheung NK, Schlom J, Finn RD. Current status of radioimmunotherapy. Nuclear Medicine and Biology. 21: 785-92. PMID 9241655 DOI: 10.1016/0969-8051(94)90050-7 |
0.42 |
|
| 1996 |
Furhang EE, Chui CS, Sgouros G. A Monte Carlo approach to patient‐specific dosimetry Medical Physics. 23: 1523-1529. PMID 8892249 DOI: 10.1118/1.597882 |
0.352 |
|
| 1996 |
Furhang EE, Sgouros G, Chui CS. Radionuclide photon dose kernels for internal emitter dosimetry Medical Physics. 23: 759-764. PMID 8724750 DOI: 10.1118/1.597670 |
0.304 |
|
| 1995 |
Ugur O, Scott AM, Kostakoglu L, Hui TE, Masterson ME, Febo R, Sgouros G, Rosa E, Mehta BM, Fisher DR, Cheung NKV, Larson SM. Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model Nuclear Medicine and Biology. 22: 87-93. PMID 7735175 DOI: 10.1016/0969-8051(94)E0066-R |
0.388 |
|
| 1994 |
Scott AM, Macapinlac HA, Zhang JJ, Kalaigian H, Graham MC, Divgi CR, Sgouros G, Goldsmith SJ, Larson SM. Clinical applications of fusion imaging in oncology Nuclear Medicine and Biology. 21: 775-784. PMID 9241654 DOI: 10.1016/0969-8051(94)90049-3 |
0.334 |
|
| 1994 |
Caron P, Jurcic J, Scott A, Finn R, Divgi C, Graham M, Jureidini I, Sgouros G, Tyson D, Old L. A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity Blood. 83: 1760-1768. DOI: 10.1182/Blood.V83.7.1760.1760 |
0.322 |
|
| 1994 |
Sgouros G, Graham MC, Jureidini IM, Humm JL, Larson SM, Scheinberg DA. PRE-CLINICAL DOSIMETRY FOR ALPHA-EMITTER-LABELED ANTIBODY THERAPY OF HEMATOLOGIC DISEASE Journal of Immunotherapy. 16: 156. DOI: 10.1097/00002371-199408000-00039 |
0.328 |
|
| 1993 |
Sgouros G, Scheinberg DA. Treatment of leukemia with radiolabeled monoclonal antibodies Cancer Treatment and Research. 68: 23-64. PMID 8105852 DOI: 10.1007/978-1-4615-3076-3_3 |
0.397 |
|
| 1989 |
Zanzonico PB, Bigler RE, Sgouros G, Strauss A. Quantitative SPECT in radiation dosimetry Seminars in Nuclear Medicine. 19: 47-61. PMID 2652307 DOI: 10.1016/S0001-2998(89)80035-2 |
0.76 |
|
| 1986 |
Bigler RE, Zanzonico P, Cosma M, Sgouros G. Adjuvant radioimmunotherapy for micrometastases: A strategy for cancer cure International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 13: 663. DOI: 10.1016/0883-2897(86)90068-1 |
0.768 |
|
| 1985 |
Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, Sgouros G, MacEwen EG. Evaluation of [1-11C]-α-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies European Journal of Nuclear Medicine. 10: 48-55. PMID 3979410 DOI: 10.1007/Bf00261763 |
0.748 |
|
| Show low-probability matches. |
